Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7967524

TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms

4+ day, 14+ hour ago   (16+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7944820

GSK pays up to $1.3B for HUTCHMED's experimental KRAS-EGFR conjugate

1+ week, 3+ day ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7940602

Novartis chooses Alteogen tech for subcutaneous drug ambitions

1+ week, 4+ day ago   (10+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7937682

Roche nabs tri-specific antibody from Simcere in $1.5B deal

1+ week, 5+ day ago   (11+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7932845

Lilly adds Merida's autoantibody-degrading tech to immunology arsenal for up to $2.9B

1+ week, 6+ day ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7912997

Spotlight On: Lilly helps clear the diagnostic path for Kisunla??? and rival Leqembi

2+ week, 6+ day ago   (15+ words) Spotlight On: Lilly helps clear the diagnostic path for Kisunla — and rival Leqembi FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7912897

FDA clears J&J's Imaavy as first treatment for rare blood disorder

2+ week, 6+ day ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7908920

Spotlight On: Ultragenyx sets $2.7 million price for newly approved GSDIa gene therapy

3+ week, 11+ hour ago   (15+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7901115

Pain drug developer Ambros to go public via reverse merger with Werewolf

3+ week, 2+ day ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7898552

Lilly links up with one of its Gateway Labs companies for vaccine collab

3+ week, 3+ day ago   (15+ words) FirstWord Pharma...